PE20061327A1 - Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion - Google Patents
Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresionInfo
- Publication number
- PE20061327A1 PE20061327A1 PE2006000418A PE2006000418A PE20061327A1 PE 20061327 A1 PE20061327 A1 PE 20061327A1 PE 2006000418 A PE2006000418 A PE 2006000418A PE 2006000418 A PE2006000418 A PE 2006000418A PE 20061327 A1 PE20061327 A1 PE 20061327A1
- Authority
- PE
- Peru
- Prior art keywords
- benzofuran
- antidepressant
- depression
- prevention
- combinations
- Prior art date
Links
- 230000001430 anti-depressive effect Effects 0.000 title abstract 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical class C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- -1 2-FLUORETHYL Chemical class 0.000 abstract 3
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 3
- GDLIGKIOYRNHDA-UHFFFAOYSA-N Clomipramine Chemical compound C1CC2=CC=C(Cl)C=C2N(CCCN(C)C)C2=CC=CC=C21 GDLIGKIOYRNHDA-UHFFFAOYSA-N 0.000 abstract 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 abstract 1
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960004606 clomipramine Drugs 0.000 abstract 1
- 229960002887 deanol Drugs 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960002464 fluoxetine Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN COMPUESTO DERIVADO DE BENZOFURANO DE FORMULA (I) Y B) UN ANTIDEPRESIVO; DONDE EN EL COMPUESTO DE FORMULA (I), R1 ES H, HALOGENO, OH, ENTRE OTROS; R2 Y R3 SON H, METILO, ETILO, 2-FLUORETILO ENTRE OTROS; Ar ES TIENILO, FURILO, PIRIDILO, ENTRE OTROS; y ES UN ENTERO DE 0 A 3; n ES 1 O 2. SON COMPUESTOS DE FORMULA (I) PREFERIDOS: (+)-(1-(7-FENIL-2,3-DIHIDRO-1-BENZOFURAN-2-IL)METANAMINA; (+)-1-[7-(3-METILFENIL)-2,3-DIHIDRO-1-BENZOFURAN-2-IL]METANAMINA; (+)-1-(7-TIEN-3-IL-2,3-DIHIDRO-1-BENZOFURAN-2-IL)METANAMINA, ENTRE OTROS. DENTRO DE LOS COMPUESTOS ANTIDEPRESIVOS SE ENCUENTRAN: CLOMIPRAMINA, AMITRIPTILINA, FLUOXETINA, DEANOL, ENTRE OTROS. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA DEPRESION U OTROS TRASTORNOS DEL TEMPERAMENTO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67404805P | 2005-04-22 | 2005-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20061327A1 true PE20061327A1 (es) | 2007-01-02 |
Family
ID=36809594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000418A PE20061327A1 (es) | 2005-04-22 | 2006-04-21 | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion |
Country Status (13)
Country | Link |
---|---|
US (2) | US7396857B2 (es) |
EP (1) | EP1871355A1 (es) |
JP (1) | JP2008536946A (es) |
CN (1) | CN101198322A (es) |
AR (1) | AR054347A1 (es) |
AU (1) | AU2006239918A1 (es) |
BR (1) | BRPI0610044A2 (es) |
CA (1) | CA2604915A1 (es) |
GT (1) | GT200600163A (es) |
MX (1) | MX2007012882A (es) |
PE (1) | PE20061327A1 (es) |
TW (1) | TW200722081A (es) |
WO (1) | WO2006116149A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
CN101175740A (zh) * | 2005-04-22 | 2008-05-07 | 惠氏公司 | 二氢苯并呋喃衍生物和其用途 |
AU2006239937A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
EP1871759A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth a Corporation of the State of Delaware | Benzodioxane and benzodioxolane derivatives and uses thereof |
BRPI0610037A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de dihidrobenzofurano e uso dos mesmos |
PE20071432A1 (es) * | 2005-04-22 | 2007-01-24 | Wyeth Corp | Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos |
AU2006239943A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Treatment of pain |
US7368477B2 (en) * | 2005-04-22 | 2008-05-06 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof |
MX2007013026A (es) * | 2005-04-22 | 2008-01-11 | Wyeth Corp | Combinaciones terapeuticas para el tratamiento o prevencion de trastornos psicoticos. |
GT200600162A (es) * | 2005-04-24 | 2007-03-14 | Metodos para modular la funcion de la vejiga | |
AR060090A1 (es) * | 2006-03-24 | 2008-05-21 | Wyeth Corp | Metodos para tratar trastornos cognitivos y otros afines |
ES2431570T3 (es) * | 2007-05-07 | 2013-11-27 | Chelsea Therapeutics, Inc. | Droxidopa y composición farmacéutica de la misma para el tratamiento de los trastornos por déficit de atención |
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
WO2011011594A2 (en) * | 2009-07-23 | 2011-01-27 | Shriners Hospitals For Children | Intracellular toll-like receptors pathways and axonal degeneration |
EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
CN102250048B (zh) * | 2011-06-03 | 2013-06-05 | 浙江工业大学 | 2-苯硒基甲基-2,3-二氢苯并呋喃及其制备与应用 |
EP3190413B1 (en) * | 2014-09-26 | 2021-08-11 | Human Metabolome Technologies, Inc. | Method for predicting depression treatment drug alternatives |
WO2020168337A1 (en) * | 2019-02-17 | 2020-08-20 | Magid Abraham | Compositions and methods for treatment of depression and other disorders |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3513239A (en) | 1967-03-15 | 1970-05-19 | Smithkline Corp | Pharmaceutical compositions containing 2-aminoalkyl coumaran derivatives and methods of treating depression therewith |
US3826835A (en) | 1971-01-08 | 1974-07-30 | Ciba Geigy Corp | 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics |
JPS59186969A (ja) | 1983-04-08 | 1984-10-23 | Yoshitomi Pharmaceut Ind Ltd | ベンゾフラン−およびベンゾピランカルボキサミド誘導体 |
JPH06316563A (ja) | 1993-05-06 | 1994-11-15 | Yoshitomi Pharmaceut Ind Ltd | アミド化合物 |
DK1738753T3 (da) | 1993-06-28 | 2008-08-11 | Wyeth Corp | Nye behandlinger under anvendelse af phenethylaminderivater |
US6150402A (en) | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
WO1996015099A1 (en) | 1994-11-09 | 1996-05-23 | Novo Nordisk A/S | Heterocyclic compounds, their preparation and use |
US5756532A (en) | 1995-11-06 | 1998-05-26 | American Home Products Corporation | Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives |
US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
DE19909760B4 (de) | 1998-04-17 | 2015-05-21 | Merck Patent Gmbh | Benzofuran-Derivate |
US7045545B1 (en) | 1999-01-27 | 2006-05-16 | Eli Lilly And Company | Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists |
SE9902267D0 (sv) | 1999-06-16 | 1999-06-16 | Astra Ab | New compounds |
US20020107244A1 (en) | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
US6969730B2 (en) | 2001-03-16 | 2005-11-29 | Abbott Laboratories | Amines as histamine-3 receptor ligands and their therapeutic applications |
KR100446235B1 (ko) | 2001-05-07 | 2004-08-30 | 엘지전자 주식회사 | 다중 후보를 이용한 움직임 벡터 병합 탐색 방법 |
WO2003029239A1 (en) | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
CN1561338A (zh) | 2001-10-04 | 2005-01-05 | 惠氏公司 | 作为5-羟基色胺-6配体的苯并二氢吡喃衍生物 |
WO2003031439A1 (en) | 2001-10-05 | 2003-04-17 | Wyeth | Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
US20030134835A1 (en) | 2002-01-11 | 2003-07-17 | Arthur Hancock | Histamine-3 receptor ligands for diabetes conditions |
US7208502B2 (en) | 2002-01-18 | 2007-04-24 | Maniv Energy Capital | Methods of treating conditions associated with an Edg-3 receptor |
US20030092770A1 (en) | 2002-10-23 | 2003-05-15 | Phil Skolnick | Combination therapy for treatment of depression |
WO2004089410A1 (ja) | 2003-04-03 | 2004-10-21 | Kyowa Hakko Kogyo Co., Ltd. | 神経因性疼痛の予防及び/または治療剤 |
EP1648455A4 (en) | 2003-07-23 | 2009-03-04 | Exelixis Inc | MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE |
US20050261347A1 (en) | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7728155B2 (en) | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
EP1710233A4 (en) | 2004-01-28 | 2009-07-15 | Kissei Pharmaceutical | NEW BENZO FURANDERIVATE, THIS MEDICAL COMPOSITION AND APPLICATIONS THEREOF |
DE102004030099A1 (de) | 2004-06-22 | 2006-01-12 | Grünenthal GmbH | Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren |
WO2006000902A1 (en) | 2004-06-25 | 2006-01-05 | Pfizer Products Inc. | Dihydrobenzofuran compounds and uses thereof |
GT200500296A (es) | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
AU2006239937A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
BRPI0610037A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de dihidrobenzofurano e uso dos mesmos |
CN101175740A (zh) | 2005-04-22 | 2008-05-07 | 惠氏公司 | 二氢苯并呋喃衍生物和其用途 |
CN101389325A (zh) | 2005-04-22 | 2009-03-18 | 惠氏公司 | 药物滥用的治疗 |
EP1879875A1 (en) | 2005-04-22 | 2008-01-23 | Wyeth | Crystal forms opf {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
PE20071432A1 (es) | 2005-04-22 | 2007-01-24 | Wyeth Corp | Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos |
MX2007013026A (es) * | 2005-04-22 | 2008-01-11 | Wyeth Corp | Combinaciones terapeuticas para el tratamiento o prevencion de trastornos psicoticos. |
AU2006239943A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Treatment of pain |
US7368477B2 (en) | 2005-04-22 | 2008-05-06 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof |
GT200600162A (es) | 2005-04-24 | 2007-03-14 | Metodos para modular la funcion de la vejiga | |
AR060090A1 (es) | 2006-03-24 | 2008-05-21 | Wyeth Corp | Metodos para tratar trastornos cognitivos y otros afines |
-
2006
- 2006-04-21 PE PE2006000418A patent/PE20061327A1/es not_active Application Discontinuation
- 2006-04-21 CN CNA2006800218927A patent/CN101198322A/zh active Pending
- 2006-04-21 CA CA002604915A patent/CA2604915A1/en not_active Abandoned
- 2006-04-21 US US11/409,480 patent/US7396857B2/en not_active Expired - Fee Related
- 2006-04-21 MX MX2007012882A patent/MX2007012882A/es not_active Application Discontinuation
- 2006-04-21 WO PCT/US2006/015191 patent/WO2006116149A1/en active Application Filing
- 2006-04-21 GT GT200600163A patent/GT200600163A/es unknown
- 2006-04-21 TW TW095114318A patent/TW200722081A/zh unknown
- 2006-04-21 EP EP06769874A patent/EP1871355A1/en not_active Withdrawn
- 2006-04-21 AR ARP060101594A patent/AR054347A1/es not_active Application Discontinuation
- 2006-04-21 AU AU2006239918A patent/AU2006239918A1/en not_active Abandoned
- 2006-04-21 JP JP2008507943A patent/JP2008536946A/ja active Pending
- 2006-04-21 BR BRPI0610044-9A patent/BRPI0610044A2/pt not_active Application Discontinuation
-
2008
- 2008-05-30 US US12/130,665 patent/US20080269321A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008536946A (ja) | 2008-09-11 |
GT200600163A (es) | 2007-03-14 |
MX2007012882A (es) | 2007-12-10 |
US20060258715A1 (en) | 2006-11-16 |
CA2604915A1 (en) | 2006-11-02 |
AR054347A1 (es) | 2007-06-20 |
TW200722081A (en) | 2007-06-16 |
CN101198322A (zh) | 2008-06-11 |
US20080269321A1 (en) | 2008-10-30 |
US7396857B2 (en) | 2008-07-08 |
BRPI0610044A2 (pt) | 2010-05-25 |
WO2006116149A1 (en) | 2006-11-02 |
AU2006239918A1 (en) | 2006-11-02 |
EP1871355A1 (en) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20061327A1 (es) | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion | |
ECSP034830A (es) | Derivados sustituidos de la ciclohexano-1,4- diamina | |
PE20070093A1 (es) | Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c | |
SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
MA31953B1 (fr) | Nouveaux derives du thiophene. | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
SE0302760D0 (sv) | New compounds | |
TW200716595A (en) | Chromane and chromene derivatives and uses thereof | |
ECSP066662A (es) | Preparación farmacéutica que comprende un anticuerpo contra el receptor egf | |
EA200970585A1 (ru) | Бензамидные производные как агонисты ер-рецепторов | |
UY27109A1 (es) | Derivados de quinazolona como antagonistas de receptores adrenergicos alfa-1a/b | |
AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
RU2008142261A (ru) | Фармацевтическая композиция с модифицированным высвобождением и ее применение | |
ATE421518T1 (de) | Dihydrochinazolinone als 5ht-modulatoren | |
AR060732A1 (es) | Usos del escitalopram | |
DK1843754T3 (da) | Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
EA200300519A1 (ru) | Соединения производных бензотиофена, способ их получения и применения | |
RU2008102238A (ru) | Таблетка, содержащая труднорастворимый активный ингредиент | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
GT200900287A (es) | Extrudidos con enmascaramiento del sabor mejorado | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
DOP2010000197A (es) | Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina | |
EA200501046A1 (ru) | Эсциталопрамгидробромид и способ его получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |